Extravasation of chemotherapeutic drug from an implantable intravenous infusion port in a child:A case report  

作　　者：Dan-Ni Lv Hong-Zhen Xu Li-Li Zheng Li-Li Chen Yun Ling A-Qin Ye 

机构地区：[1]Department of Surgical Oncology,The Children’s Hospital,Zhejiang University School of Medicine,National Clinical Research Center for Child Health,Hangzhou 310052,Zhejiang Province,China [2]Department of Nursing,The Children’s Hospital,Zhejiang University School of Medicine,National Clinical Research Center for Child Health,Hangzhou 310052,Zhejiang Province,China

出　　处：《World Journal of Clinical Cases》2021年第26期7840-7844,共5页世界临床病例杂志

基　　金：Supported by Department of Education of Zhejiang Province,China,No.Y201941241.

摘　　要：BACKGROUND Drug extravasation is a complication of totally implantable access port(TIAP)use and could cause tissue injury and sustained organ dysfunction.Therefore,the clinical management of children with TIAP is challenging.CASE SUMMARY This was a case of extravasation of a chemotherapeutic drug(paclitaxel)from an implantable infusion port in a 23-mo old child.After fully evaluating the skin at the site of extravasation,the nurse continued to use the infusion port to complete the follow-up chemotherapeutic course.The skin around the infusion port was red,and showed no ulceration,swelling,or induration at discharge.CONCLUSION Since children are more active and often noncompliant,it is necessary to appropriately train pediatric nurses caring for individuals with TIAPs,and any abnormal situation should be timely addressed.

关 键 词：Infusion port PACLITAXEL EXTRAVASATION Nursing Children Case report 

分 类 号：R473.72[医药卫生—护理学]